During the course of my review of recent premarket approvals (PMAs), I was once again startled (although I certainly shouldn’t be, having not too long ago done this same exercise on patent approvals) by the dominance of Medtronic. As an exercise (because exercise is important), I decided to just graph the January 2009 premarket approvals [...]
bookmark to
